"Radiation" covers a wide range of exposures, and the question of whether it causes hair loss has very different answers depending on which kind you mean. The dose of radiation from a dental X-ray, a chest film, or even a CT scan is far too low to affect a hair follicle. Radiation therapy aimed at treating cancer is an entirely different situation: it delivers a concentrated, targeted dose that can and often does cause hair loss, but only in the specific area being treated, and frequently on a timeline and with a reversibility that surprises people. This guide separates the everyday exposures that do not cause shedding from the therapeutic doses that do, explains the biology behind radiation-related hair loss, and lays out what the evidence says about when hair grows back.
This is an education piece. If you are facing radiation therapy or have recently finished it, the most reliable source of information about your specific case is your radiation oncology team, who know the exact dose, field, and fractionation involved in your treatment.
Diagnostic imaging does not cause hair loss
The radiation people encounter most often comes from medical imaging: X-rays, CT scans, mammograms, and dental films. The doses involved are measured in fractions of a gray (Gy), the unit used for absorbed radiation. Hair follicles do not begin to show even temporary effects until the local skin dose reaches several gray delivered to that specific spot (Ounsakul et al., Case Rep Dermatol Med, 2016). A single diagnostic scan is orders of magnitude below that threshold, and the dose is not concentrated on the scalp the way therapeutic radiation is.
The clearest real-world exceptions are prolonged fluoroscopy procedures, such as some endovascular embolizations for brain aneurysms, where the X-ray beam dwells on one area of the scalp for an extended time. A handful of case reports describe a patch of temporary hair loss appearing a few weeks after these long procedures, in the exact shape of the beam's entry point (Ounsakul et al., Case Rep Dermatol Med, 2016). These are uncommon, the loss is almost always temporary, and they are a function of an unusually long single exposure, not routine imaging. For the vast majority of diagnostic scans, hair loss is simply not a concern.
How radiation therapy causes hair loss
Radiation therapy works by damaging the DNA of rapidly dividing cells, which is why it is effective against tumors. Hair follicle matrix cells, the cells at the base of an actively growing follicle, are among the fastest-dividing cells in the body, and they are caught in the same crossfire. When a radiation field includes hair-bearing skin, those matrix cells take direct damage.
The result is anagen effluvium: the loss of hairs that are in the active growth phase (anagen). Unlike the telogen effluvium that follows illness or major stress, where there is a two- to three-month lag before shedding, anagen effluvium is fast. The damaged follicles produce a weakened hair shaft that breaks off, and visible loss typically appears within one to three weeks of treatment beginning (Ounsakul et al., Case Rep Dermatol Med, 2016). Some follicles are also pushed prematurely into the resting phase, adding a slower wave of telogen-type shedding on top of the immediate anagen loss.
The single most important feature of radiation-related hair loss is that it is localized to the treatment field. Radiation does not cause the all-over thinning that chemotherapy can. Hair is lost only where the beam enters and exits. A person receiving radiation to the brain may lose hair in a band across the scalp while the rest grows normally; a person receiving radiation to the breast, pelvis, or another site away from the head usually keeps their scalp hair entirely. This is the opposite of the diffuse, whole-scalp shedding seen in telogen effluvium or the scattered pattern of pattern hair loss.
Temporary versus permanent: it comes down to dose
Whether the hair grows back depends largely on how much radiation the scalp skin received, and there is a reasonably well-described dose-response relationship.
At lower therapeutic doses, the follicle's matrix cells are damaged but its stem cell reservoir, the bulge region that regenerates the follicle for each new growth cycle, survives. When the bulge stem cells are preserved, the follicle can re-enter the growth cycle and the hair regrows. When those stem cells are depleted or the surrounding tissue becomes scarred and fibrotic, the loss becomes permanent (Phillips et al., Support Care Cancer / J Am Acad Dermatol analyses, 2020).
Translating that into numbers, the literature on intracranial radiation therapy generally finds that temporary scalp hair loss appears at cumulative doses around 20 Gy, while permanent loss becomes likely once the scalp itself receives roughly 30 to 36 Gy or more. A frequently cited retrospective analysis of brain tumor patients found that a cranial dose of about 43 Gy was associated with permanent alopecia in half of patients, establishing one of the clearest dose thresholds in the field (Lawenda et al., Int J Radiat Oncol Biol Phys, 2004). These figures are why modern radiation planning, including scalp-sparing techniques, increasingly tries to keep the dose to non-target scalp below the permanent-loss threshold whenever the clinical situation allows.
For most patients receiving lower-dose or well-shielded treatment, the loss is temporary. For those whose treatment requires high doses to hair-bearing scalp, some degree of permanent thinning in the treated area is a realistic outcome to discuss with the care team in advance.
The regrowth timeline
When hair does come back after radiation, the timeline is slower and less predictable than the regrowth after chemotherapy. Temporary radiation-induced hair loss typically begins to recover two to four months after treatment ends, but full regrowth in the treated field can take six months to a year, and sometimes longer for higher doses near the reversible threshold.
Regrown hair is often different from the original. Patients commonly report that hair returns finer, with a changed texture (straighter or curlier than before), and occasionally a different color. The treated patch may also stay permanently less dense than the surrounding scalp even when it is not fully bald, because a fraction of follicles in the field did not survive. These changes reflect partial follicle recovery rather than a new disease process.
A separate phenomenon worth knowing about is radiation recall: hair loss or skin reactions in a previously irradiated field that flare up later when certain chemotherapy drugs are given. This is one more reason the full treatment history matters when interpreting hair changes after cancer care.
What about radioactive iodine and other indirect routes?
Radioactive iodine, used to treat some thyroid conditions and thyroid cancer, is a common source of confusion. The iodine concentrates in thyroid tissue, not in hair follicles, so it does not cause anagen effluvium the way external beam radiation to the scalp does. When people notice shedding after radioactive iodine, the more likely mechanism is the thyroid disruption itself: both an overactive and underactive thyroid can drive diffuse telogen effluvium, and the physiologic stress of the underlying illness contributes as well. Correcting the thyroid hormone levels usually allows that shedding to recover.
The broader point is that cancer treatment rarely happens in isolation. Surgery, anesthesia, nutritional changes, weight loss, and the emotional toll of a serious diagnosis can each independently trigger telogen effluvium across the whole scalp, layered on top of any localized loss from the radiation field itself. The nutritional deficiencies that affect hair, particularly low iron and protein during a difficult treatment period, can compound the picture.
When the question is really about pattern hair loss
Sometimes a person finishes radiation, watches the treated area recover, and then becomes newly attentive to thinning elsewhere on the scalp, at the temples, the crown, or the part line, that does not match the radiation field at all. That distribution is the signature of androgenetic alopecia, the common hormonally driven pattern loss that progresses on its own timeline and is unrelated to the radiation. A stressful illness can make people notice pattern loss that was already underway, the same way an episode of telogen effluvium can unmask it.
Pattern hair loss is a different process with its own evidence-based options, including minoxidil and finasteride. It is generally not appropriate to start those treatments on scalp that is actively recovering from radiation without a physician's input, both because the area needs time to heal and because the cause of the loss in the treated field is structural follicle damage rather than the hormonal mechanism those medications address. The two situations call for different management, and telling them apart is the first step.
A reasonable way to think about radiation and hair
Everyday medical imaging does not cause hair loss. Radiation therapy can, but only in the area being treated, on a fast anagen-effluvium timeline, and with a reversibility that depends heavily on the dose the scalp skin received. Lower doses with surviving follicle stem cells usually regrow, often with a changed texture, over six months to a year. Higher doses can leave a permanently thinner patch in the treated field. None of this resembles the diffuse shedding of telogen effluvium or the patterned thinning of androgenetic alopecia, and the distinction guides what, if anything, can be done about it.
If you are weighing radiation treatment, questions about expected hair loss, the dose to non-target scalp, and scalp-sparing planning options are reasonable to raise with your radiation oncologist before treatment starts. If you have finished treatment and are noticing thinning in a pattern that does not match where the beam was aimed, that may be a separate question about pattern hair loss worth raising with a physician. Curekey's hair assessment is one way to start that conversation with a U.S.-licensed clinician, though it is not a substitute for the oncology team managing radiation-related effects directly.
Related reading
- Stress and hair loss: telogen effluvium: the diffuse, whole-scalp shedding that often accompanies serious illness and surgery, distinct from localized radiation loss.
- How the hair growth cycle works: why follicles in the active growth phase are the most vulnerable to radiation and chemotherapy.
- Nutritional deficiencies that cause hair loss: how iron, protein, and other shortfalls during treatment can compound shedding.
- What is androgenetic alopecia: the hormonally driven pattern loss sometimes noticed after, but unrelated to, radiation.
- How it works: what a Curekey assessment and physician review look like.
